Circular Genomics launches antidepressant response test

The new SSRI antidepressant test uses circular RNA biomarkers to improve precision in psychiatry.

Circular Genomics has introduced MindLight, a test designed to predict the response of patients with depression to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.

View remaining article on Medical Device Network